• Neurogene held its annual shareholder meeting on June 3, 2026.
• Shareholders backed the selection of Robert Baffi, Rohan Palekar as Class III directors, with terms running to the 2029 annual meeting.
• Investors endorsed a non-binding say-on-pay resolution.
• Shareholders ratified Deloitte & Touche as independent auditor for the year ending Dec. 31, 2026.
• A non-binding vote favored holding future say-on-pay votes annually; the board plans to follow that schedule unless it later changes course.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001404644-26-000040), on June 04, 2026, and is solely responsible for the information contained therein.